Milestone Demonstrates the Value of Research, Development and Investment in
Pro-innovation and Patient-centered Policies Are Critical to Sustain Momentum
NEW YORK, Dec. 4, 2013 /PRNewswire/ -- U.S. life expectancy for people with
cancer hit another all-time high, rising over 50 million life-years after
diagnosis. The estimate of approximately 50 million life-years saved is based on
the number of additional years of life that each person diagnosed with cancer
since 1990 has experienced as a result of advances in science and broader access
to novel cancer therapies. This is based on statistics collected through the
Value of Medical Innovation initiative, led by the Center for Medicine in the
Public Interest (CMPI), promoting a world free from cancer by 2050. CMPI
cautions, however, that those gains could be at risk if the policy environment
and healthcare system at large do not accelerate access to the innovations
responsible for longer lives and declines in cancer-related death rates.
(Logo: http://photos.prnewswire.com/prnh/20131204/NY27779LOGO )
According to CMPI co-founder Robert Goldberg, Ph.D., "The benefits of medical
innovation to patients and their families can be counted in birthdays,
anniversaries, weddings and other life events that would have been missed if it
weren't for medical innovation."
In 1990, there were about six million cancer survivors in the United States.
Today, there are about 14 million. Back then, about 57 percent of cancer
patients could expect to live five years or more. Today, that number is nearly
70 percent. And the value that innovative therapies bring by way of longer life,
productivity, consumer consumption of goods, increasing healthcare system
efficiencies and societal prosperity is more than $4.8 trillion.
"We're at a turning point in battling cancer," said Scott Gottlieb, M.D.,
resident fellow for the American Enterprise Institute. "Doctors are finally able
to reliably tailor treatments to the unique genetic composition of each
patient's tumor rather than by its location in the body alone. Other new drugs
are able to prime our own immune cells to attack cancers."
Research suggests that even greater gains in life-years--along with a decline in
the cost of treating cancer--are possible through personalized medicine, which
reduces the cost and time of treatment compared with the old one-size-fits-all
model. "We shouldn't endanger the gains we've made and risk future advances by
limiting or delaying access to the next generation of medicines," states
Goldberg. "We can achieve a world free from cancer, but only if we continue to
speed the development and use of innovations that have allowed us to reach 50
million life-years saved over the past two decades."
ValueofInnovation.org is a community of patients, advocates, innovators and
concerned citizens working together to generate awareness of the Value of
Medical Innovation to longer life, better health and increased economic
well-being. We believe that a world free from cancer is possible if we reduce
the time it takes to develop new cancer treatments and get them to patients. We
seek to ensure that health plans and government policies encourage use of
personalized treatment of tumors. ValueofInnovation.org also promotes collective
action to remove the obstacles to using rapid advances in science to make cancer
a preventable and manageable illness.
ValueofInnovation.org is an independent project of The Center for Medicine in
the Public Interest (CMPI, www.cmpi.org). CMPI has promoted public-private
partnerships to accelerate and protect medical innovation, developed a pathway
for personalized medicine and raised concerns about the use of comparative
effectiveness research on innovation and access to treatment. The Value of
Medical Innovation initiative is in line with the CMPI's mission. The CMPI is
dedicated to promoting innovative solutions that advance medical progress,
reduce health disparities, extend life and make health care more affordable,
preventive and patient-centered.
The methodology of the Life-Years-Saved Clock and other information about the
relationship between innovation and progress against cancer can be found at
The Center for Medicine in the Public Interest is a nonprofit, nonpartisan
research and educational organization that seeks to advance the discussion and
development of the value of medical innovation.
SOURCE Center for Medicine in the Public Interest